Table of Contents

company-logo

Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a combination therapy for non or never-smokers with non-small cell lung cancer adenocarcinoma. In addition, its preclinical development drug candidate is LP-184, an alkylating agent that damages DNA in cancer cells that overexpress certain biomarkers or that harbor mutations in DNA repair pathways. Further, the company operates ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. Additionally, the company's artificial intelligence platform RADR uses big data analytics and machine learning for combining molecular data. The company was incorporated in 2013 and is headquartered in Dallas, Texas.

Lantern Pharma Dividend Announcement

• Lantern Pharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Lantern Pharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Lantern Pharma Dividend History

Lantern Pharma Dividend Yield

Lantern Pharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Lantern Pharma stock? Use our calculator to estimate your expected dividend yield:

Lantern Pharma Financial Ratios

P/E ratio-2.34
PEG ratio0.09
P/B ratio1.68
ROE-56.90%
Payout ratio0.00%
Current ratio8.31
Quick ratio8.31
Cash Ratio2.25

Lantern Pharma Dividend FAQ

Does Lantern Pharma stock pay dividends?
Lantern Pharma does not currently pay dividends to its shareholders.
Has Lantern Pharma ever paid a dividend?
No, Lantern Pharma has no a history of paying dividends to its shareholders. Lantern Pharma is not known for its dividend payments.
Why doesn't Lantern Pharma pay dividends?
There are several potential reasons why Lantern Pharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Lantern Pharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Lantern Pharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Lantern Pharma a dividend aristocrat?
Lantern Pharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Lantern Pharma a dividend king?
Lantern Pharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Lantern Pharma a dividend stock?
No, Lantern Pharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Lantern Pharma stocks?
To buy Lantern Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Lantern Pharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.